Next Article in Journal
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?
Next Article in Special Issue
Hybrid Dihydropyrimidinones Targeting AKT Signaling: Antitumor Activity in Hormone-Dependent 2D and 3D Cancer Models
Previous Article in Journal
Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs
Previous Article in Special Issue
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(10), 1322; https://doi.org/10.3390/pharmaceutics17101322
Action Date Notes Link
article html file updated 11 October 2025 15:35 CEST Original file https://www.mdpi.com/1999-4923/17/10/1322/html
article pdf uploaded. 11 October 2025 15:34 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1322/pdf
article xml uploaded. 11 October 2025 15:34 CEST Update https://www.mdpi.com/1999-4923/17/10/1322/xml
article xml file uploaded 11 October 2025 15:34 CEST Original file -
Back to TopTop